(Q30424507)

English

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials (English)

1 reference

Europe PubMed Central

13 August 2017

phase III clinical trial

0 references

Daniel J. Sargent

object named as

Daniel Sargent

5

0 references

Craig Slingluff

12

object named as

Craig L Slingluff

1 reference

Europe PubMed Central

13 August 2017

Benjamin Djulbegovic

13

object named as

Benjamin Djulbegovic

1 reference

Europe PubMed Central

13 August 2017

author name string

Anneke T Schroen

1

1 reference

Europe PubMed Central

13 August 2017

Gina R Petroni

2

1 reference

Europe PubMed Central

13 August 2017

Hongkun Wang

3

1 reference

Europe PubMed Central

13 August 2017

Monika J Thielen

4

1 reference

Europe PubMed Central

13 August 2017

Jacqueline K Benedetti

6

1 reference

Europe PubMed Central

13 August 2017

Walter M Cronin

7

1 reference

Europe PubMed Central

13 August 2017

Donald L Wickerham

8

1 reference

Europe PubMed Central

13 August 2017

Xiaofei F Wang

9

1 reference

Europe PubMed Central

13 August 2017

Robert Gray

10

1 reference

Europe PubMed Central

13 August 2017

Wendy F Cohn

11

1 reference

Europe PubMed Central

13 August 2017

publication date

30 August 2011

1 reference

Europe PubMed Central

13 August 2017

Clinical Trials

1 reference

Europe PubMed Central

13 August 2017

8

1 reference

Europe PubMed Central

13 August 2017

5

1 reference

Europe PubMed Central

13 August 2017

591-600

1 reference

Europe PubMed Central

13 August 2017

A sense of urgency: Evaluating the link between clinical trial development time and the accrual performance of cancer therapy evaluation program (NCI-CTEP) sponsored studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Strategies to improve recruitment to research studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Choosing a control intervention for a randomised clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Factors that limit the quality, number and progress of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Barriers to participation in randomised controlled trials: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Response rates to mail surveys published in medical journals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Equipoise and the ethics of clinical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3474201

20 June 2018

Managing accrual in cooperative group clinical trials.

1 reference

https://api.crossref.org/works/10.1177%2F1740774511419683

21 January 2018

Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates

1 reference

https://pubmed.ncbi.nlm.nih.gov/21878447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1177/1740774511419683

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30424507&oldid=1549554094"